Lyell Immunopharma (LYEL) EBIT (2020 - 2026)
Lyell Immunopharma (LYEL) recorded EBIT of -$47.34 million in Q2 2026, compared with -$47.14 million a year earlier.
Powered by 
Analysis
Lyell Immunopharma (LYEL) EBIT (2020 - 2026) Analysis & Trends
On a TTM basis, Lyell Immunopharma's EBIT came in at -$256.5 million as of Jun 30, 2026; for FY2025, it came in at -$269.4 million.
- Across earlier years, EBIT came in at -$358.76 million in FY2024, -$247.01 million in FY2023, -$187.06 million in FY2022 and -$214.78 million in FY2021.
- Quarterly EBIT has ranged from -$201.15 million in Q4 2024 to -$14.78 million in Q4 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$44.26 million (Q1 2026), -$127.64 million (Q4 2025) and -$37.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Lyell Immunopharma | 220.79 Mn | -804.18 Mn | - | -47.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.34 Mn |
| Mar 31, 2026 | -44.26 Mn |
| Dec 31, 2025 | -127.64 Mn |
| Sep 30, 2025 | -37.25 Mn |
| Jun 30, 2025 | -47.14 Mn |
| Mar 31, 2025 | -57.37 Mn |
| Dec 31, 2024 | -201.15 Mn |
| Sep 30, 2024 | -50.51 Mn |
| Jun 30, 2024 | -51.53 Mn |
| Mar 31, 2024 | -55.58 Mn |
| Dec 31, 2023 | -59.51 Mn |
| Sep 30, 2023 | -59.04 Mn |
| Jun 30, 2023 | -65.91 Mn |
| Mar 31, 2023 | -62.56 Mn |
| Dec 31, 2022 | -14.78 Mn |
| Sep 30, 2022 | -66.44 Mn |
| Jun 30, 2022 | -37.26 Mn |
| Mar 31, 2022 | -68.58 Mn |
| Dec 31, 2021 | -47.54 Mn |
| Sep 30, 2021 | -49.16 Mn |
API Access
Lyell Immunopharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();